These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 11719669)

  • 61. Contrast enhancement of central nervous system lesions: multicenter intraindividual crossover comparative study of two MR contrast agents.
    Maravilla KR; Maldjian JA; Schmalfuss IM; Kuhn MJ; Bowen BC; Wippold FJ; Runge VM; Knopp MV; Kremer S; Wolansky LJ; Anzalone N; Essig M; Gustafsson L
    Radiology; 2006 Aug; 240(2):389-400. PubMed ID: 16801373
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.
    Low RN; Francis IR; Herfkens RJ; Jeffrey RB; Glazer GM; Foo TK; Shimakawa A; Pelc NJ
    AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The value of gadobenate dimeglumine-enhanced hepatobiliary-phase MR imaging for the differentiation of scirrhous hepatocellular carcinoma and cholangiocarcinoma with or without hepatocellular carcinoma.
    Jeon TY; Kim SH; Lee WJ; Lim HK
    Abdom Imaging; 2010 Jun; 35(3):337-45. PubMed ID: 19350315
    [TBL] [Abstract][Full Text] [Related]  

  • 64. MRI of focal nodular hyperplasia (FNH) with gadobenate dimeglumine (Gd-BOPTA) and SPIO (ferumoxides): an intra-individual comparison.
    Fröhlich JM
    J Magn Reson Imaging; 2004 Mar; 19(3):375-6; author reply 376. PubMed ID: 14994308
    [No Abstract]   [Full Text] [Related]  

  • 65. Hepatocellular carcinoma in liver transplantation candidates: detection with gadobenate dimeglumine-enhanced MRI.
    Choi SH; Lee JM; Yu NC; Suh KS; Jang JJ; Kim SH; Choi BI
    AJR Am J Roentgenol; 2008 Aug; 191(2):529-36. PubMed ID: 18647927
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.
    Bauner KU; Reiser MF; Huber AM
    Invest Radiol; 2009 Feb; 44(2):95-104. PubMed ID: 19077911
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Efficacy of gadobenate dimeglumine vs gadopentetate dimeglumine in contrast- enhanced magnetic resonance imaging for diagnosis of solitary brain metastases].
    Wang QJ; Wang Y; Xu X; Xiao H; Ma L
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Dec; 31(12):1968-73. PubMed ID: 22200693
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis.
    Grazioli L; Bondioni MP; Haradome H; Motosugi U; Tinti R; Frittoli B; Gambarini S; Donato F; Colagrande S
    Radiology; 2012 Feb; 262(2):520-9. PubMed ID: 22282184
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Autoimmune pancreatitis: pancreatic and extrapancreatic MR imaging-MR cholangiopancreatography findings at diagnosis, after steroid therapy, and at recurrence.
    Manfredi R; Frulloni L; Mantovani W; Bonatti M; Graziani R; Pozzi Mucelli R
    Radiology; 2011 Aug; 260(2):428-36. PubMed ID: 21613442
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Detection of malignant primary hepatic neoplasms with gadobenate dimeglumine (Gd-BOPTA) enhanced T1-weighted hepatocyte phase MR imaging: results of off-site blinded review in a phase-II multicenter trial.
    Peña CS; Saini S; Baron RL; Hamm BA; Morana G; Caudana R; Giovagnoni A; Villa A; Carriero A; Mathieu D; Bourne MW; Kirchin MA; Pirovano G; Spinazzi A
    Korean J Radiol; 2001; 2(4):210-5. PubMed ID: 11754328
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Focal nodular hyperplasia of the liver on ferumoxides-enhanced MR imaging: features on conventional spin-echo, fast spin-echo and gradient-echo pulse sequences.
    Precetti-Morel S; Bellin MF; Ghebontni L; Zaïm S; Opolon P; Poynard T; Mathurin P; Cluzel P
    Eur Radiol; 1999; 9(8):1535-42. PubMed ID: 10525860
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Splenic hemangiomas and hamartomas: MR imaging characteristics of 28 lesions.
    Ramani M; Reinhold C; Semelka RC; Siegelman ES; Liang L; Ascher SM; Brown JJ; Eisen RN; Bret PM
    Radiology; 1997 Jan; 202(1):166-72. PubMed ID: 8988207
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Safety, tolerance, biodistribution, and MR imaging enhancement of the liver with gadobenate dimeglumine: results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteers.
    Spinazzi A; Lorusso V; Pirovano G; Kirchin M
    Acad Radiol; 1999 May; 6(5):282-91. PubMed ID: 10228617
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Focal nodular hyperplasia: lesion characteristics on state-of-the-art MRI including dynamic gadolinium-enhanced and superparamagnetic iron-oxide-uptake sequences in a prospective study.
    Terkivatan T; van den Bos IC; Hussain SM; Wielopolski PA; de Man RA; IJzermans JN
    J Magn Reson Imaging; 2006 Oct; 24(4):864-72. PubMed ID: 16947339
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Solid focal liver lesions: dynamic and late enhancement patterns with the dual phase contrast agent gadobenate dimeglumine.
    Grazioli L; Bondioni MP; Faccioli N; Gambarini S; Tinti R; Schneider G; Kirchin M
    J Gastrointest Cancer; 2010 Dec; 41(4):221-32. PubMed ID: 20405242
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Differentiating focal nodular hyperplasia from hepatocellular adenoma: Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful?
    Roux M; Pigneur F; Baranes L; Calderaro J; Chiaradia M; Decaens T; Kastahian S; Charles-Nelson A; Tselikas L; Costentin C; Laurent A; Azoulay D; Mallat A; Rahmouni A; Luciani A
    Abdom Radiol (NY); 2018 Jul; 43(7):1670-1681. PubMed ID: 29110059
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Assessment of sequential enhancement patterns of focal nodular hyperplasia and hepatocellular carcinoma on mangafodipir trisodium enhanced MR imaging.
    Savellano DH; Köstler H; Baus S; Mössinger M; Gratz KF; Weimann A; Galanski M
    Invest Radiol; 2004 May; 39(5):305-12. PubMed ID: 15087726
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Quantitative correlation between uptake of Gd-BOPTA on hepatobiliary phase and tumor molecular features in patients with benign hepatocellular lesions.
    Reizine E; Amaddeo G; Pigneur F; Baranes L; Legou F; Mulé S; Zegai B; Roche V; Laurent A; Rahmouni A; Calderaro J; Luciani A
    Eur Radiol; 2018 Oct; 28(10):4243-4253. PubMed ID: 29721686
    [TBL] [Abstract][Full Text] [Related]  

  • 79. MR imaging patterns of gadolinium retention within liver neoplasms.
    Peterson MS; Murakami T; Baron RL
    Abdom Imaging; 1998; 23(6):592-9. PubMed ID: 9922191
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Intrahepatic mass-forming cholangiocarcinoma: enhancement pattern on Gd-BOPTA-MRI with emphasis of hepatobiliary phase.
    Mamone G; Marrone G; Caruso S; Carollo V; Gentile G; Crino' F; Milazzo M; Luca A
    Abdom Imaging; 2015 Oct; 40(7):2313-22. PubMed ID: 25962708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.